Shanthi Nagarajan

516 total citations
22 papers, 385 citations indexed

About

Shanthi Nagarajan is a scholar working on Molecular Biology, Computational Theory and Mathematics and Cancer Research. According to data from OpenAlex, Shanthi Nagarajan has authored 22 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 4 papers in Computational Theory and Mathematics and 4 papers in Cancer Research. Recurrent topics in Shanthi Nagarajan's work include Receptor Mechanisms and Signaling (5 papers), Computational Drug Discovery Methods (4 papers) and NF-κB Signaling Pathways (4 papers). Shanthi Nagarajan is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Computational Drug Discovery Methods (4 papers) and NF-κB Signaling Pathways (4 papers). Shanthi Nagarajan collaborates with scholars based in United States, South Korea and India. Shanthi Nagarajan's co-authors include Ae Nim Pae, Sugunadevi Sakkiah, Amy J. Eshleman, Aaron Janowsky, John F. Reed, Katherine M. Wolfrum, Aaron Nilsen, Jeyaraman Jeyakanthan, Khuraijam Dhanachandra Singh and Palani Kirubakaran and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

Shanthi Nagarajan

21 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanthi Nagarajan United States 11 206 77 55 52 51 22 385
Maryann L. Shen United States 8 154 0.7× 56 0.7× 20 0.4× 23 0.4× 24 0.5× 8 368
Teng-Kuang Yeh Taiwan 15 372 1.8× 64 0.8× 24 0.4× 113 2.2× 292 5.7× 26 832
Clara T. Schoeder Germany 15 284 1.4× 191 2.5× 170 3.1× 49 0.9× 48 0.9× 41 680
Agostino Bruno Italy 18 453 2.2× 118 1.5× 15 0.3× 53 1.0× 154 3.0× 35 715
Kamila Siedlecka-Kroplewska Poland 14 199 1.0× 20 0.3× 34 0.6× 41 0.8× 23 0.5× 21 374
Mark L. J. Reimer Canada 8 161 0.8× 29 0.4× 15 0.3× 63 1.2× 39 0.8× 17 412
Giampiero Colombano Italy 9 210 1.0× 22 0.3× 24 0.4× 51 1.0× 101 2.0× 11 447
Atsushi Kimishima Japan 11 113 0.5× 82 1.1× 85 1.5× 9 0.2× 111 2.2× 27 387
Marco Migliore United States 12 148 0.7× 46 0.6× 31 0.6× 30 0.6× 94 1.8× 19 469
Paul A. Glossop United Kingdom 13 187 0.9× 70 0.9× 20 0.4× 13 0.3× 221 4.3× 29 591

Countries citing papers authored by Shanthi Nagarajan

Since Specialization
Citations

This map shows the geographic impact of Shanthi Nagarajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanthi Nagarajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanthi Nagarajan more than expected).

Fields of papers citing papers by Shanthi Nagarajan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanthi Nagarajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanthi Nagarajan. The network helps show where Shanthi Nagarajan may publish in the future.

Co-authorship network of co-authors of Shanthi Nagarajan

This figure shows the co-authorship network connecting the top 25 collaborators of Shanthi Nagarajan. A scholar is included among the top collaborators of Shanthi Nagarajan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanthi Nagarajan. Shanthi Nagarajan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abrego, Jaime, Chet Oon, Xiao Xu, et al.. (2022). A Cancer Cell–Intrinsic GOT2–PPARδ Axis Suppresses Antitumor Immunity. Cancer Discovery. 12(10). 2414–2433. 34 indexed citations
2.
Langelier, Marie-France, Ilsa T. Kirby, Daniel S. Bejan, et al.. (2022). Allosteric regulation of DNA binding and target residence time drive the cytotoxicity of phthalazinone-based PARP-1 inhibitors. Cell chemical biology. 29(12). 1694–1708.e10. 7 indexed citations
3.
Alkayed, Nabil J., Zhiping Cao, Shanthi Nagarajan, et al.. (2022). Control of coronary vascular resistance by eicosanoids via a novel GPCR. American Journal of Physiology-Cell Physiology. 322(5). C1011–C1021. 26 indexed citations
4.
Nagarajan, Shanthi, et al.. (2021). Mapping the Molecular Architecture Required for Lipid-Binding Pockets Using a Subset of Established and Orphan G-Protein Coupled Receptors. Journal of Chemical Information and Modeling. 61(7). 3442–3452. 2 indexed citations
5.
Eshleman, Amy J., Shanthi Nagarajan, Katherine M. Wolfrum, et al.. (2020). Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors. Biochemical Pharmacology. 182. 114293–114293. 41 indexed citations
6.
Davis, Catherine M., Shanthi Nagarajan, Kristin L. Scott, et al.. (2019). RANOLAZINE EXHIBITS ANTI-ISCHEMIC PROPERTIES BY INCREASING CARDIAC ENDOTHELIAL CELL ADENOSINE LEVELS. Journal of the American College of Cardiology. 73(9). 48–48. 1 indexed citations
7.
Nagarajan, Shanthi, Nabil J. Alkayed, Sanjiv Kaul, & Anthony P. Barnes. (2019). Effect of thermostable mutations on the neurotensin receptor 1 (NTSR1) activation state. Journal of Biomolecular Structure and Dynamics. 38(2). 340–353. 6 indexed citations
8.
Eshleman, Amy J., Shanthi Nagarajan, Katherine M. Wolfrum, et al.. (2018). Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters. Psychopharmacology. 236(3). 939–952. 50 indexed citations
9.
Nagarajan, Shanthi & Sugunadevi Sakkiah. (2018). Exploring a potential allosteric inhibition mechanism in the motor domain of human Eg-5. Journal of Biomolecular Structure and Dynamics. 37(9). 2394–2403. 9 indexed citations
10.
Nagarajan, Shanthi, et al.. (2015). Insilico docking evaluation of bacterial derived anticancer (Lectin) Protein with different oncogene protein.
11.
Nagarajan, Shanthi, Min Jeong Choi, Yong Seo Cho, et al.. (2015). Tubulin Inhibitor Identification by Bioactive Conformation Alignment Pharmacophore‐Guided Virtual Screening. Chemical Biology & Drug Design. 86(5). 998–1016. 7 indexed citations
12.
Nagarajan, Shanthi, Dimitrios A. Skoufias, Frank Kozielski, & Ae Nim Pae. (2012). Receptor–Ligand Interaction-Based Virtual Screening for Novel Eg5/Kinesin Spindle Protein Inhibitors. Journal of Medicinal Chemistry. 55(6). 2561–2573. 32 indexed citations
13.
Singh, Khuraijam Dhanachandra, Palani Kirubakaran, Shanthi Nagarajan, et al.. (2011). Homology modeling, molecular dynamics, e-pharmacophore mapping and docking study of Chikungunya virus nsP2 protease. Journal of Molecular Modeling. 18(1). 39–51. 79 indexed citations
14.
Nagarajan, Shanthi, Hyunah Choo, Yong Seo Cho, et al.. (2010). IKKβ inhibitor identification: a multi-filter driven novel scaffold. BMC Bioinformatics. 11(S7). S15–S15. 12 indexed citations
15.
Nagarajan, Shanthi, Hyunah Choo, Yong Seo Cho, et al.. (2010). IKKβ inhibitors identification part II: Ligand and structure-based virtual screening. Bioorganic & Medicinal Chemistry. 18(11). 3951–3960. 14 indexed citations
16.
Nagarajan, Shanthi, Asif Ahmed, Hyunah Choo, et al.. (2010). 3D QSAR pharmacophore model based on diverse IKKβ inhibitors. Journal of Molecular Modeling. 17(2). 209–218. 10 indexed citations
17.
Nagarajan, Shanthi, Munikumar Reddy Doddareddy, Hyunah Choo, et al.. (2009). IKKβ inhibitors identification part I: Homology model assisted structure based virtual screening. Bioorganic & Medicinal Chemistry. 17(7). 2759–2766. 29 indexed citations
18.
Jeyakanthan, Jeyaraman, Subbiah Thamotharan, Devadasan Velmurugan, et al.. (2009). New structural insights and molecular-modelling studies of 4-methyl-5-β-hydroxyethylthiazole kinase fromPyrococcus horikoshiiOT3 (PhThiK). Acta Crystallographica Section F Structural Biology and Crystallization Communications. 65(10). 978–986. 3 indexed citations
19.
Nagarajan, Shanthi, et al.. (2006). DrugMetZ DB: an anthology of human drug metabolizing Chytochrome P450 enzymes. Bioinformation. 1(7). 248–250. 1 indexed citations
20.
Nagarajan, Shanthi & Parthiban Marimuthu. (2006). Binding site prediction of galanin peptide using evolutionary trace method. Bioinformation. 1(5). 180–183. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maryann L. Shen Breakdown of academic impact, for papers by Teng-Kuang Yeh Breakdown of academic impact, for papers by Clara T. Schoeder Breakdown of academic impact, for papers by Agostino Bruno Breakdown of academic impact, for papers by Kamila Siedlecka-Kroplewska Breakdown of academic impact, for papers by Mark L. J. Reimer Breakdown of academic impact, for papers by Giampiero Colombano Breakdown of academic impact, for papers by Atsushi Kimishima Breakdown of academic impact, for papers by Marco Migliore Breakdown of academic impact, for papers by Paul A. Glossop
Rankless by CCL
2026